Skip to main content
. 2018 Nov 24;6(1):4–14. doi: 10.1002/acn3.653

Table 1.

Mean (SD) demographic characteristics of patients and controls

HC naPPA lvPPA svPPA P
n 31 15 23 21
Age, y 69.29 (7.90) 69.67 (9.20) 65.91 (9.83) 64.48 (7.71) 0.14
Sex = Male (%) 11 (35.5) 6 (40.0) 7 (30.4) 10 (47.6) 0.68
Education, y 15.97 (2.58) 14.80 (3.12) 15.35 (3.19) 15.10 (2.81) 0.56
Disease duration, y NA 2.60 (1.12) 4.00 (2.00) 4.05 (2.04) 0.04
MMSE total (0‐30), n = 85 29.00 (1.07) 24.73 (5.24) 23.05 (5.72) 23.05 (6.11) <0.001a
PBAC Naming (0‐6), n = 37 5.50 (0.71) 5.78 (0.67) 4.00 (1.83) 1.23 (1.48) <0.001
F letter fluency, n = 41 17.75 (8.10) 6.33 (3.04) 6.36 (5.40) 8.21 (3.96) 0.001
Digit span forward, n = 69 7.00 (1.37) 5.61 (1.30) 4.45 (1.54) 6.06 (1.89) <0.001
Digit span backward, n = 74 5.65 (1.31) 2.64 (1.11) 2.91 (1.08) 3.78 (1.70) <0.001
Category fluencyd, n = 54 19.67 (6.48) 10.11 (5.09) 9.85 (5.94) 5.36 (4.67) <0.001
Total speech timeb (sec) 49.66 (18.23) 33.78 (18.53) 38.54 (15.02) 36.42 (13.85) 0.006
Total word countc 166.32 (63.90) 65.80 (37.06) 114.13 (56.80) 134.05 (55.99) <0.001
Speech rate, wpm 140.06 (36.74) 61.00 (24.85) 88.17 (36.09) 113.95 (40.76) <0.001
MLU (words) 10.57 (1.98) 6.74 (2.38) 8.46 (2.45) 8.61 (2.75) <0.001
DC/utterancee 0.37 (0.23) 0.05 (0.09) 0.21 (0.21) 0.32 (0.27) <0.001
WFS/utterance  0.91 (0.11) 0.72 (0.32) 0.71 (0.25) 0.78 (0.19) 0.003

wpm, words per minute; MLU, mean length of utterance; DC, dependent clauses; WFS, well‐formed sentences; PBAC, Philadelphia Brief Assessment of Cognition.

a

MMSE total score did not differ between patient groups.

b

This refers to the sum of all subject's speech segment durations, including verbal and nonverbal vocalizations, all available for pitch‐tracking.

c

This manual word count includes only verbal vocalizations that were comprehensible enough for transcription.

d

Category = animals

e

Data refer to the average number of clauses per utterance.